“◐의외로◑여탑 ∈ yeotop4.com ∋매교동오피✈매교동출장❄매교동오피ಅ매교동풀싸롱✎매교동립카페Ⅱ매교동휴게텔○매교동건마”的搜索结果，显示 641-650 项，共有 12267 项

1. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Rochester, Minn. This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as ...

2. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2-hydroxyglutarate (2HG) and, therefore, differentiate between IDH-mutant and wild-type gliomas. Arizona Alzheimer's Disease Research Center (ADRC-001).

5. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the thalamus area of the brain using stereotactic electroencephalography (an EEG with deep electrode ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   [1, 2] The solid tumor stroma acts as an immunosuppressive cloud that ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also ...

9. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...